Role of total mesorectal excision and of circumferential resection margin in local recurrence and survival of patients with rectal carcinoma

Digestive Diseases

Volumn 25, Issue 1, 2007, Pages 51-55

  Tzardi, Maria ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Circumferential resection margin; Rectal cancer, histological findings; Rectal cancer, prognostic factors; Rectal carcinoma; Total mesorectal excision

Indexed keywords

CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; HISTOLOGY; HUMAN; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; RECTUM CARCINOMA; REVIEW; SURGICAL TECHNIQUE; TOTAL MESORECTAL EXCISION;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33947580808     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099170     Document Type: Review

References (38)

1. Compton CC: Pathologic prognostic factors in the recurrence of rectal cancer. Clin Colorectal Cancer 2002;2:149-160.
2. Heald RJ, Ryal RD: Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;i:1479-1482.
3. Nilsson E, Gregersen NP, Hartvig B: Carcinoma of the colon and rectum. Acta Chir Scand 1984;150:513-516.
4. Wang C, Zhou ZG, Wang Z, Li L, Zheng YC, Zhao GP, Chen DY, Liu WP: Mesorectal spread and micrometastasis of rectal cancer studied with large slice technique and tissue microarray. J Surg Oncol 2005;91:167-172.
5. The Pathological Aspect of Rectal Cancer. The TME Workshop by the Pelican Cancer Foundation, 2002.
6. Nagtegaal ID, van Krieken JHJM: The role of pathologists in the quality control of diagnosis and treatment of rectal cancer - an overview. Eur J Cancer 2002;38:964-972.
7. Quirke P: Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol 2003;4:695-702.
8. Quirke P: Limitations of existing system of staging for rectal cancer; in Rectal Cancer Surgery: Optimization, Standardization and Documentation. Berlin, Springer, 1997, vol 63, p 8132.
9. Nagtegaal ID: Pathological aspects of rectal carcinoma. Studies from RT + TME trial; PhD thesis, Nijmegen 2002.
10. Arbman G, Nilsson E, Hallbook O, Siodahl R: Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996;83:375-379.
11. Norwegian Rectal Cancer Group: Total mesorectal excision in Norway: a national rectal cancer project. Dis Colon Rectum 1999;42:A26.
12. Martling A, Singnomklao T, Holm T, Rutqvist LE, Cedermark B: Prognostic significance of both surgical and pathological assessment of curative resection for rectal cancer. Br J Surg 2004;91:1040-1045.
13. Faerden AE, Naimy N, Wiik P, Reiertsen O, Weyessa S, Tronnes S, Norheim Andersen S, Bakka A: Total mesorectal excision for rectal cancer: difference in outcome for low and high rectal cancer. Dis Colon Rectum 2005;48:2224-2231.
14. Ueno H, Mochizuki H, Hashiguchi Y, Hase K: Prognostic determinants of patient with lateral nodal involvement by rectal cancer. Ann Surgy 2001;234:190-197.
15. Emslie J, Beart R, Mohiuddin M, Marks G: Use of rectal cancer position as a prognostic indicator. Am Surg 1998;64:958-961.
16. Lee SH, Hernandez de Anda E, Finne CO, Madoff RD, Garcia-Aguila J: The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision. Dis Colon Rectum 2005;48:2249-2257.
17. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedermark B, Stockholm Colorectal Cancer Study Group: Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Basingstoke Bowel Cancer Research Project. Lancet 2000;356:93-96.
18. Nesbakkem A, Nygaard K, Westerheim O, Mala T, Lunde OC: Local recurrence after mesorectal excision for rectal cancer. Eur J Surg Oncol 2002;28:126-134.
19. Balch GC, De Meo A, Guillem JG: Modern management of rectal cancer. World J Gastroenterol 2006;12:3186-3195.
20. Nagtegaal ID, van der Velde CJH, van der Worp E, Kapiteijin E, Quirke P: Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 2002;20:1729-1734.
21. Quirke P, Durdey P, Dixon MF, Williams NS: Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Lancet 1986;ii:996-999.
22. Quirke P, Dixon MF: The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorect Dis 1988;3:127-131.
23. Hermanek P, Junginger T: The circumferential resection margin in rectal carcinoma surgery. Tech Coloproctol 2005;9:193-200.
24. Wang Z, Zhou ZG, Wang C, Zhao GP, Chen YD, et al: Microscopic spread of low rectal cancer in regions of mesorectum: pathologic assessment with whole-mount sections. World J Gastroenterol 2004;10:2949-2953.
25. Wang C, Zhou ZG, Wang Z, Chen YD, et al: Nodal spread and micrometastasis within mesorectum. World J Gastroenterol 2005;11:3586-3590.
26. Wang C, Zhou ZG, Wang Z, Zheng Y, et al: Patterns of neoplastic foci and lymph node micrometastasis within mesorectum. Langenbecks Arch Surg 2005;390:312-318.
27. Quirke P, Williams GT: Minimum Dataset for Colorectal Cancer: Histopathology Reports. London, Royal College of Pathologists, 2004.
28. Nagtegaal ID, Maijnen CAM, Kranenbarg EK, van de Velde CJK, van Krieken JHM: Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002;26:350-357.
29. Birbeck KF, Macklin GP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, Abbott CR, Scott N, Finan PJ, Johnston D, Quirke P: Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surgery 2002;235:449-457.
30. Adam IJ, Mohamdee MO, Martin IG: Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-11.
31. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Soreide O: Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002;89:327-334.
32. Madoff RD, Sharon L, Dykes, MD: What's new in colon and rectal surgery. J Am Coll Surg 2004;198:91-104.
33. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Soreide O, Norwegian Rectal Cancer Group: Oncological outcomes after total mesorectal excision for cure for cancer lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum 2004;47:48-58.
34. Hermanek P, Wittekind C: The pathologist and the residual tumor (R) classification. Pathol Res Pract 1994;190:115-123.
35. Kapiteijn E, Marijnen CA, Nagteggal ID, et al: Preoperative radiotherapy combined with total mesorectal excision for respectable rectal cancer. N Engl J Med 2001;345:638-646.
36. Oberholzen K, Junginger T, Kreitner KF, Krummenauer F, Simiantonaki N, Trouet S, Thelen M: Local staging of rectal carcinoma and assessment of the circumferential resection margin with high-resolution MRI using an integrated parallel acquisition technique. J Magn Reson Imaging 2005;22:101-108.
37. Mathur P, Smith JJ, Ramsey C, Owen M, Thorpe A, Karim S, Burke C, Ramesh S, Dawson PM: Comparison of CT and MRI in the preoperative staging of rectal adenocarcinoma and prediction of circumferential resection margin involvement by MRI. Colorectal Dis 2003;5:396-401.
38. Beets-Tan RGH, Beets GL: Rectal cancer: review with emphasis on MRI. Radiology 2004;232:335-346.